Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Change in Account Payables: 2012-2025

Historic Change in Account Payables for Veracyte (VCYT) over the last 13 years, with Sep 2025 value amounting to -$3.7 million.

  • Veracyte's Change in Account Payables fell 194.21% to -$3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.9 million, marking a year-over-year increase of 41.82%. This contributed to the annual value of -$4.3 million for FY2024, which is 3112.69% down from last year.
  • Veracyte's Change in Account Payables amounted to -$3.7 million in Q3 2025, which was up 8.66% from -$4.0 million recorded in Q2 2025.
  • Veracyte's 5-year Change in Account Payables high stood at $7.1 million for Q1 2025, and its period low was -$4.0 million during Q2 2025.
  • Moreover, its 3-year median value for Change in Account Payables was -$1.2 million (2023), whereas its average is -$453,273.
  • Data for Veracyte's Change in Account Payables shows a peak YoY increase of 561.14% (in 2025) and a maximum YoY decrease of 2,373.46% (in 2025) over the last 5 years.
  • Over the past 5 years, Veracyte's Change in Account Payables (Quarterly) stood at $1.3 million in 2021, then slumped by 62.82% to $477,000 in 2022, then slumped by 166.88% to -$319,000 in 2023, then crashed by 324.76% to -$1.4 million in 2024, then tumbled by 194.21% to -$3.7 million in 2025.
  • Its Change in Account Payables stands at -$3.7 million for Q3 2025, versus -$4.0 million for Q2 2025 and $7.1 million for Q1 2025.